GLP-1 Tracker is a health-tracking utility for iOS that allows users to log GLP-1 medication dosages, side effects, and body measurements.
The App DNA
What makes this app unique?
Users need a way to correlate medication timing with symptom levels to manage their weight loss journey, which this app serves via a structured logging interface.
For Individuals currently prescribed GLP-1 medications who require a structured way to monitor weight loss, side effects, and medication adherence.
What does it look like?
Key features
Logs injections, patches, and pills by date, location, and dosage; historical views are gated behind a subscription.
Records side effects and daily feelings to create a habit loop that increases session frequency.
Biometric authentication for health records, providing privacy assurance that reduces churn risk.
How much does it cost?
The freemium model gates historical data, advanced metrics, and cross-device sync behind a subscription, offering a 7-day free trial to drive conversion.
Velocity
Dormant developmentmonetizationUX improvementsShow more...
The app has been inactive for 429 days, falling well outside the threshold for active development. With only one version recorded in the analyzed window, there is no evidence of ongoing maintenance or feature iteration. The development momentum is currently stagnant.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for GLP-1 Tracker
How's the Health & Fitness market?
GLP-1 Tracker occupies a niche in the Health & Fitness category, relying on a subscription-gated utility model. The 14-month update gap (last release July 2025) signals a shift toward maintenance-mode, limiting its ability to compete with active entrants.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GLP-1 Tracker
Where is it heading?
The health-tracking market is consolidating around apps with frequent feature updates and community-driven support. GLP-1 Tracker's 14-month development gap leaves it exposed, as users will likely migrate to more active alternatives that provide better historical data access.
- The 14-month development gap (last release July 2025) indicates maintenance-mode, which reduces the app's ability to retain users against active competitors.
- Restricting historical data to the premium tier limits the free-tier utility, which likely suppresses the conversion funnel for new users.
The SWOT
- FaceID biometric integration provides a defensible privacy barrier for sensitive health data.
- Levels symptom logging creates a high-frequency habit loop that increases session frequency.
- The lack of recent updates suggests a market gap for a more active, community-driven GLP-1 tracking solution.
Next best moves
Audit premium gating because historical tracking is locked behind a subscription → improve free-tier retention
+ 1 more prioritized moveThe counter-intuitive read
The app's silence is its biggest risk…
Read the full takeBottom line
GLP-1 Tracker relies on a privacy-first utility model, but the 14-month development gap threatens its long-term viability. Pivoting the premium gating strategy to allow more historical access would improve free-tier retention and provide a clearer value proposition for potential subscribers.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated